Pharmacological Modulation of Inflammatory Pathways in Sepsis: Targeting the Cytokine Storm and Septic Oxidative Stress

Sepsis is a major health challenge characterized by an excessive immune response, leading to cytokine storms and oxidative stress, which can result in tissue damage and organ failure. Recent advancements emphasize the need to understand and target these inflammatory pathways pharmacologically. Despite significant research, the complexity of these responses often hampers the development of effective treatments.

This Research Topic aims to explore the pharmacological modulation of inflammatory pathways in sepsis, focusing on cytokine management and oxidative stress reduction. This topic seeks to uncover potential therapeutic targets and strategies that could improve patient outcomes. We aim to address critical questions such as identifying pivotal cytokines, quantifying oxidative stress, and evaluating promising pharmacological agents, both novel and repurposed.

To gather further insights into targeting inflammatory pathways in sepsis, we welcome articles addressing, but not limited to, the following themes:

- Mechanisms of cytokine storms in sepsis
- Biomarkers for monitoring inflammation
- Pharmacological strategies to modulate oxidative stress
- Innovations in anti-inflammatory treatments for sepsis
- Immunometabolic reprogramming in sepsis
- Nanotechnology-based drug delivery for sepsis
- Clinical trials on novel sepsis therapies
- Personalized medicine approaches in sepsis management

We encourage submissions of Original Research, Review, and Case Reports articles that contribute to advancing sepsis management.

Keywords: sepsis, cytokine storm, oxidative stress, inflammatory pathways, cytokine management, anti-inflammatory treatments

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.